Viorgon-18

Testis tissue parenchyma bioregulator.

Composition: 1 ml of a sterile solution contains: 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of a protein-peptide complex isolated from the tissue of the testes of mature bulls.

Physiological effect: Viorgon-18 is associated with its property to additionally activate cellular sources of regeneration in the parenchymal tissue of the testes, to maintain the viability of spermatozoa.

Recommendations for use: Viorgon-18 is recommended for use in male infertility associated with low mobility and / or low sperm viability, with a cyst and other diseases of the testes. Viorgon-18 is combined with other viorgons (especially viorgon-1).

Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.

Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.

A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.

The interval between the various viorgons is at least 10 minutes.